IRIS
ALTAMURA, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.053
NA - Nord America 2.870
EU - Europa 1.148
SA - Sud America 547
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 51
OC - Oceania 14
AN - Antartide 1
Totale 11.736
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 5.341
US - Stati Uniti d'America 2.774
CN - Cina 705
IT - Italia 586
HK - Hong Kong 464
BR - Brasile 412
VN - Vietnam 222
GB - Regno Unito 143
FR - Francia 122
BD - Bangladesh 96
DE - Germania 92
IN - India 56
AR - Argentina 52
CA - Canada 44
ID - Indonesia 37
NL - Olanda 31
EC - Ecuador 30
EE - Estonia 22
FI - Finlandia 21
MX - Messico 21
TR - Turchia 20
RU - Federazione Russa 19
CO - Colombia 17
UA - Ucraina 16
AT - Austria 15
ZA - Sudafrica 15
IQ - Iraq 14
PH - Filippine 14
JP - Giappone 13
AU - Australia 12
SA - Arabia Saudita 12
ES - Italia 10
SE - Svezia 10
MD - Moldavia 9
MY - Malesia 9
PK - Pakistan 9
CZ - Repubblica Ceca 8
MA - Marocco 8
PL - Polonia 8
VE - Venezuela 8
CL - Cile 7
JM - Giamaica 7
PE - Perù 7
PY - Paraguay 7
DZ - Algeria 6
HN - Honduras 6
HR - Croazia 5
KZ - Kazakistan 5
TN - Tunisia 5
UZ - Uzbekistan 5
AL - Albania 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
LT - Lituania 4
NP - Nepal 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CR - Costa Rica 3
EG - Egitto 3
GE - Georgia 3
GR - Grecia 3
GT - Guatemala 3
HU - Ungheria 3
KE - Kenya 3
KR - Corea 3
SN - Senegal 3
SV - El Salvador 3
ET - Etiopia 2
JO - Giordania 2
MT - Malta 2
OM - Oman 2
PS - Palestinian Territory 2
RO - Romania 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
FJ - Figi 1
GY - Guiana 1
IL - Israele 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MS - Montserrat 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
Totale 11.678
Salva come PNG Salva come JPEG
Città #
San Jose 725
Ashburn 565
Hong Kong 458
Singapore 436
Rome 298
Hefei 237
Beijing 176
Council Bluffs 162
Dallas 143
Columbus 134
Boardman 114
London 110
Lauterbourg 102
Shanghai 81
Ho Chi Minh City 79
New York 62
Santa Clara 57
Hanoi 54
Phoenix 52
São Paulo 44
San Francisco 40
Los Angeles 39
Munich 29
Milan 28
Sona 22
Pune 18
Amsterdam 14
Frankfurt am Main 14
Seattle 14
Toronto 14
Nuremberg 13
Quito 13
Florence 12
Naples 12
Washington 12
Rio de Janeiro 11
Chicago 10
Guayaquil 10
Helsinki 10
Montreal 10
Tokyo 10
West Jordan 10
Brasília 9
Chennai 9
Las Vegas 9
Redmond 9
Turku 9
Bologna 8
Brooklyn 8
Stockholm 8
Warsaw 8
Atlanta 7
Baghdad 7
Joinville 7
Mexico City 7
Orem 7
Porto Alegre 7
Turin 7
Boston 6
Brno 6
Buffalo 6
Genoa 6
Haiphong 6
Houston 6
Philadelphia 6
Can Tho 5
Charlotte 5
Denver 5
Dhaka 5
Edinburgh 5
Istrana 5
Johannesburg 5
Lima 5
Manaus 5
Manchester 5
Melbourne 5
Miami 5
Quảng Ngãi 5
Santa Fe 5
Staten Island 5
Tashkent 5
Vienna 5
Buenos Aires 4
Caxias do Sul 4
Curitiba 4
Da Nang 4
Delhi 4
Feira de Santana 4
Ha Long 4
Hortolândia 4
Jeddah 4
Kathmandu 4
Kingston 4
Ninh Bình 4
Niterói 4
Novara 4
Oklahoma City 4
Osasco 4
Paris 4
Pittsburgh 4
Totale 4.779
Salva come PNG Salva come JPEG
Nome #
1-Hz repetitive transcranial magnetic stimulation increases cerebral vasomotor reactivity: a possible autonomic nervous system modulation 398
Stroke territory and atherosclerosis in ischemic stroke patients with a history of migraine with aura 267
Hyperhomocysteinemia, intima-media thickness and C677T MTHFR gene polymorphism: A correlation study in patients with cognitive impairment 261
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 261
Psychopathological variables in chronic migraine patients with different therapeutic approach: psychological profile differences and impact on therapeutic efficacy in real life 241
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 235
Task-switching abilities in episodic and chronic migraine 234
Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment 230
OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study 229
Acute Carotid Dissection in an Adult Caused by Pertussis 227
Correction to: Task-switching abilities in episodic and chronic migraine (Neurological Sciences, (2022), 10.1007/s10072-021-05837-4) 221
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project 218
Eptinezumab for the Prevention of Migraine: Clinical Utility, Patient Preferences and Selection - A Narrative Review 209
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment 206
Cerebral Hemodynamics, Right-to-Left Shunt and White Matter Hyperintensities in Patients with Migraine with Aura, Young Stroke Patients and Controls 206
Cerebral distribution of white matter lesions in migraine with aura patients 204
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 203
CAROTID WALL THICKNESS AND STROKE RISK IN PATIENTS WITH ASYMPTOMATIC INTERNAL CAROTID STENOSIS 200
Cerebral vasomotor reactivity in the acute phase and after 6 months in non-disabling stroke/TIA: A prospective cohort study 191
Right-to-Left Shunt and the Clinical Features of Migraine with Aura: Earlier but Not More 186
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study 160
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study 156
Cerebral Hemodynamics, Patent foramen ovale and White Matter Hyperintensities in patients Migraine with aura, young stroke patients and controls 154
Frequency and clinical implications of hypercoagulability states in a cohort of patients with migraine with aura 149
Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter study 132
Gepants - a long way to cure: a narrative review 130
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 129
Carotid Artery Plaque Progression: Proposal of a New Predictive Score and Role of Carotid Intima-Media Thickness 129
Blood pressure monitoring in elderly migraineurs starting an anti-CGRP monoclonal antibody: a real-world prospective study 128
Relationship among diffusion tensor imaging, EEG activity, and cognitive status in mild cognitive impairment and Alzheimer's disease patients 126
Acute medications' intake for migraine: a one-year report in patients undergoing first evaluation at a third level Italian headache center 125
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 122
Antioxidant status and APOE genotype as susceptibility factors for neurodegeneration in Alzheimer's disease and vascular dementia 121
Bilateral MCP Infarct Due to Vertebral Giant Cell Arteritis 118
Calcitonin Gene-Related Peptide Systemic Effects: Embracing the Complexity of Its Biological Roles-A Narrative Review 117
Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study 116
Embodying an artificial hand increases blood flow to the investigated limb [version 3; peer review: 2 approved] 115
Cerebrovascular reactivity predicts stroke in high-grade carotid artery disease 115
Effect of Atogepant on Sleep Quality and Sleep-Related Adverse Events in Adult Patients with Migraine: A Prospective Observational 12-Week Study 115
Regional MRI Diffusion, White-Matter Hyperintensities, and Cognitive Function in Alzheimer's Disease and Vascular Dementia 114
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study 111
Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease 109
Cerebrovascular assessment for the risk prediction of Alzheimer's disease 109
Diffusion-weighted lesions after carotid artery stenting are associated with cognitive impairment 107
Ceruloplasmin/Transferrin system is related to clinical status in acute stroke 105
Patients with migraine with aura have increased flow mediated dilation 103
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 98
The role of endothelial dysfunction in the pathophysiology and cerebrovascular effects of migraine: A narrative review 97
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 89
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 80
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) 78
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients 71
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study 68
The evolving concept of multimorbidity and migraine 68
Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study 67
Reducing the Impact of Headache and Allodynia Score in Chronic Migraine: An Exploratory Analysis from the Real-World Effectiveness of Anti-CGRP Monoclonal Antibodies Compared to Onabotulinum Toxin A (RAMO) Study 65
Vascular predictors of cognitive decline in patients with mild cognitive impairment 64
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 64
Shorter visual aura characterizes young and middle-aged stroke patients with migraine with aura 63
Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study 63
Cognitive performance is related to ceruloplasmin/transferrin system in patients with chronic hepatitis 62
fMRI-vs-MEG evaluation of post-stroke interhemispheric asymmetries in primary sensorimotor hand areas 62
Erenumab does not alter cerebral hemodynamics and endothelial function in migraine without aura 60
Does cerebrovascular disease affect the coupling between neuronal activity and local haemodynamics? 60
Gadolinium Enhancement in a Case of Uncomplicated Posterior Reversible Encephalopathy Syndrome 59
Cortical ischemic lesion burden measured by DIR is related to carotid artery disease severity 59
Cortical neuromodulation modifies cerebral vasomotor reactivity 59
The Healthy Eating Plate Advice for Migraine Prevention: An Interventional Study 59
Markers for the risk of progression from mild cognitive impairment to Alzheimer's disease 57
Patent foramen ovale and migraine with aura in a retrospective analysis: age matters 57
Markers of lacunar stroke in patients with moderate internal carotid artery stenosis 57
Serotonin depletion and barrel cortex development: impact of growth impairment vs. serotonin effects on thalamocortical endings 56
Pathophysiological Bases of Comorbidity in Migraine 56
Emerging Risk Factors for Dementia: The Role of Blood Pressure Variability 55
Thresholds of impaired cerebral hemodynamics that predict short-term cognitive decline in asymptomatic carotid stenosis 54
Internal jugular vein valve incompetence in transient global amnesia: more circumstantial evidence or the proof solving the mystery? 54
Dorsolateral medullary ischemic infarction causing autonomic dysfunction and headache: a case report 51
High frequency repetitive transcranial magnetic stimulation decreases cerebral vasomotor reactivity 51
Neuronal functionality assessed by magnetoencephalography is related to oxidative stress system in acute ischemic stroke 49
Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men 49
Onabotulinumtoxin-A in Chronic Migraine: Should Timing and Definition of Non-Responder Status Be Revised? Suggestions From a Real-Life Italian Multicenter Experience 48
Hypercapnia affects the functional coupling of resting state electroencephalographic rhythms and cerebral haemodynamics in healthy elderly subjects and in patients with amnestic mild cognitive impairment 48
Ruolo delle mappe ADC nella diagnosi differenziale tra demenza vascolare e demenza di Alzheimer 48
When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway? 48
Ultrasonographic markers of vascular risk in patients with asymptomatic carotid stenosis 47
The Role of White Matter Damage in the Risk of Periprocedural Diffusion-Weighted Lesions after Carotid Artery Stenting. 46
Neuroimaging experimental studies on brain plasticity in recovery from stroke 46
One-year progression of moderate asymptomatic carotid stenosis predicts the risk of vascular events 46
Influence of chronotype on migraine characteristics 45
Cognitive deterioration in bilateral asymptomatic severe carotid stenosis 45
Postpartum cerebellar infarction and haemolysis, elevated liver enzymes, low platelet (HELLP) syndrome 44
What is the relationship among atherosclerosis markers, apolipoprotein E polymorphism and dementia? 44
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study) 44
Transient global amnesia and jugular vein incompetence response 43
Right-to-left shunts and hormonal therapy influence cerebral vasomotor reactivity in patients with migraine with aura 43
Daith Piercing in a Case of Chronic Migraine: A Possible Vagal Modulation 43
Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration 43
Lack of correlation between cerebral vasomotor reactivity and flow-mediated dilation in subjects without vascular disease 43
Early activation of intracranial collateral vessels influences the outcome of spontaneous internal carotid artery dissection 42
Commentary: Enhanced Hemodynamic and Clinical Response to αCGRP in Migraine Patients—A TCD Study 42
Totale 10.901
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.431
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022128 0 0 0 0 0 0 0 0 17 4 0 107
2022/202366 2 2 2 2 7 4 4 11 7 4 17 4
2023/2024348 17 40 12 31 36 144 5 27 6 10 9 11
2024/20255.796 43 44 123 11 14 68 106 62 322 411 2.235 2.357
2025/20264.337 371 258 339 588 177 218 1.084 235 345 319 254 149
2026/20271.058 81 462 331 184 0 0 0 0 0 0 0 0
Totale 11.736